General Gynecology | Page 9 of 13 | Links Medicus Content Curation & Alerts in Medicine

UK clinical guideline for the prevention and treatment of osteoporosis.

11 Apr, 2022 | 01:33h | UTC

UK clinical guideline for the prevention and treatment of osteoporosis – Archives of Osteoporosis

M-A: Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives.

6 Apr, 2022 | 10:55h | UTC

Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: Systematic review and meta-analysis – Journal of Thrombosis and Haemostasis

Systematic Review: There is insufficient evidence to support or refute the use of antibiotics for preventing infection following surgery to treat stress urinary incontinence in women.

4 Apr, 2022 | 00:26h | UTC

Prophylactic antibiotics for preventing infection after continence surgery in women with stress urinary incontinence – Cochrane Library

Summary: Antibiotics for preventing infection following surgery to treat stress urinary incontinence in women – Cochrane Library

Commentary on Twitter

New review: do prophylactic antibiotics prevent infection after continence surgery in stress urinary incontinence in women? Read now via the @CochraneLibrary: https://t.co/tSIDgPU6UA pic.twitter.com/846iTjNyBH

— Cochrane Incontinence (@C_Incontinence) March 30, 2022

RCT: Single-incision mini-slings for stress urinary incontinence in women.

31 Mar, 2022 | 08:35h | UTC

Single-Incision Mini-Slings for Stress Urinary Incontinence in Women – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Single-incision mini-slings effective for stress urinary incontinence in women – Healio (free registration required)

Commentary on Twitter

For stress urinary incontinence in women, mini-slings were noninferior to midurethral slings with respect to patient-reported success at 15 months. https://t.co/Ag5p2u2WZW pic.twitter.com/PcajqXTiLW

— NEJM (@NEJM) March 30, 2022

Guidance on the need for contraception related to use of pharmaceuticals: providing information on the proper use of pharmaceuticals in patients with reproductive potential.

31 Mar, 2022 | 07:49h | UTC

Guidance on the need for contraception related to use of pharmaceuticals: the Japan Agency for Medical Research and Development Study Group for providing information on the proper use of pharmaceuticals in patients with reproductive potential

Retrospective Cohort Study: Risks for anaphylaxis with intravenous iron formulations.

30 Mar, 2022 | 10:16h | UTC

Risks for Anaphylaxis With Intravenous Iron Formulations: A Retrospective Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)

News Release: Risk of Severe Allergic Reaction Higher with Two Intravenous Iron-Boosting Products – Rutgers University

Commentary: Risks for Anaphylaxis Compared Among IV Iron Products – HealthDay

Cohort Study: Association of lower extremity lymphedema with physical functioning and activities of daily living among older survivors of colorectal, endometrial, and ovarian cancer.

28 Mar, 2022 | 08:39h | UTC

Association of Lower Extremity Lymphedema With Physical Functioning and Activities of Daily Living Among Older Survivors of Colorectal, Endometrial, and Ovarian Cancer – JAMA Network Open

Commentaries:

Older female cancer survivors face challenges with physical activity due to chronic lower extremity lymphedema – News Medical

Lower-Extremity Lymphedema Common in Older, Female Cancer Survivors – HealthDay

Commentary on Twitter

Cohort study found nearly 1/3 of older female survivors of #ColorectalCancer, #EndometrialCancer, or #OvarianCancer have lower-extremity lymphedema (LEL), which is associated with worse physical function and needing assistance with ADLs. https://t.co/806Tt88TuV

— JAMA Network Open (@JAMANetworkOpen) March 9, 2022

SEOM-GEICO clinical guidelines on endometrial cancer.

25 Mar, 2022 | 08:24h | UTC

SEOM-GEICO clinical guidelines on endometrial cancer (2021) – Clinical and Translational Oncology

[News release – not published yet] RCT: Minimally invasive approach to hysterectomy in cervical cancer is associated with poorer disease-free survival than open surgery.

24 Mar, 2022 | 08:47h | UTC

Minimally Invasive Approach to Hysterectomy in Cervical Cancer Associated with Poorer Disease-Free Survival Than Open Surgery – Society of Gynecologic Oncology

Outcomes and safety of history-based screening for medication abortion: a retrospective multicenter cohort study.

22 Mar, 2022 | 08:11h | UTC

Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study – JAMA Internal Medicine

Invited Commentary: It Is Time to Change the Standard of Medication Abortion – JAMA Internal Medicine (free for a limited period)

M-A: Risk of peritoneal carcinomatosis after risk-reducing salpingo-oophorectomy in BRCA1/2 pathogenic variant (PV) carriers.

22 Mar, 2022 | 07:58h | UTC

Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis – Journal of Clinical Oncology

Multi-disciplinary care planning of ovarian cancer in older patients.

18 Mar, 2022 | 07:55h | UTC

Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement—A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO – Cancers

Trends in HPV–associated cancers, demographic characteristics, and vaccinations in the US, 2001-2017.

17 Mar, 2022 | 08:16h | UTC

Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017 – JAMA Network Open

Author Interview: Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations

[Not published yet] Single-dose HPV vaccine highly effective, researchers say – “Results of randomized controlled trial in Kenya bring new energy to eliminate cervical cancer worldwide”.

A national HPV vaccination program in England was associated with an estimated reduction in cervical cancer rates of 87% for those offered the vaccine at age 12–13 years.

Three-year follow-up of 2-dose versus 3-dose HPV vaccine

Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer

CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination

Meta-Analysis: Population-level Impact of HPV Vaccination Programs

Systematic Review: Perioperative enhanced recovery programs for women with gynecological cancers.

16 Mar, 2022 | 10:05h | UTC

Perioperative enhanced recovery programmes for women with gynaecological cancers – Cochrane Library

See also: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines (some guidelines are free)

Management and care of patients with invasive cervical cancer: ASCO resource-stratified guideline rapid recommendation update.

14 Mar, 2022 | 00:40h | UTC

Management and Care of Patients With Invasive Cervical Cancer: ASCO Resource-Stratified Guideline Rapid Recommendation Update – JCO Global Oncology

News Release: ASCO Guideline Recommends Addition of Monoclonal Antibody to Invasive Cervical Cancer Management – ASCO Daily News

RCT: Methenamine Hippurate (a non-antibiotic preventive treatment) is noninferior to prophylactic antibiotics for treating recurrent urinary tract infections in women.

11 Mar, 2022 | 10:21h | UTC

Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial – The BMJ

News Release: Antiseptic drug as good as antibiotics for preventing recurrent urinary tract infections – BMJ Newsroom

Editorial: Methenamine hippurate for recurrent urinary tract infections – The BMJ

Commentaries:

Trial supports antibiotic alternative for recurrent urinary infections – CIDRAP

Nonantibiotic Prophylaxis Noninferior for Recurrent UTI – HealthDay

Commentary on Twitter

The antiseptic drug methenamine hippurate is as good as antibiotics for preventing recurrent urinary tract infections in women, finds this trial

Includes a visual abstract displaying the findings #BMJInfographic https://t.co/LJNx2OEKhO @chrisharding123 pic.twitter.com/CjxWtjao6r

— The BMJ (@bmj_latest) March 10, 2022

Cancer risks other than female breast and ovarian cancers associated with BRCA1 and BRCA2 pathogenic variants.

3 Mar, 2022 | 08:14h | UTC

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants – Journal of Clinical Oncology

Commentary: Faulty BRCA genes linked to prostate and pancreatic cancers – University of Cambridge

Guideline Update: Timing of elective surgery and risk assessment after SARS-CoV-2 infection – “The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting”.

1 Mar, 2022 | 08:58h | UTC

Timing of elective surgery and risk assessment after SARS-CoV-2 infection: an update – Anaesthesia

Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of Covid-19.

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

BJS commission on surgery and perioperative care post-COVID-19.

The risk of postoperative complications following major elective surgery in active or resolved COVID-19 in the United States – Major, elective surgery 0–4 weeks after Covid-19 is associated with greatly increased risk of postoperative complications; surgery performed 4–8 weeks after infection is still associated with an increased risk of pneumonia.

ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.

Position statement: Perioperative management of post-COVID-19 surgical patients.

Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19

M-A: Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer.

24 Feb, 2022 | 10:02h | UTC

Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis – Journal of Clinical Oncology (link to abstract – $ for full-text)

Commentary: Meta-Analysis Affirms Survival Benefit of Second Surgery in Ovarian Cancer — Mortality decreased with rising rates of complete, optimal cytoreduction at recurrence – MedPage Today (free registration required)

RCT: Cytoreductive surgery for relapsed ovarian cancer.

Guide to enhanced recovery for cancer patients undergoing surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without hyperthermic intraperitoneal chemotherapy.

RCT: Single-dose metronidazole vs. treatment for 7 days for treating Trichomonas vaginalis in women.

21 Feb, 2022 | 08:23h | UTC

A Comparison of Single-Dose Versus Multidose Metronidazole by Select Clinical Factors for the Treatment of Trichomonas vaginalis in Women – Sexually Transmitted Diseases (link to abstract – $ for full-text)

Global, regional, and national prevalence estimates of physical or sexual, or both, intimate partner violence against women.

18 Feb, 2022 | 08:44h | UTC

Global, regional, and national prevalence estimates of physical or sexual, or both, intimate partner violence against women in 2018 – The Lancet

News release: More than a quarter of women have experienced intimate partner violence in their lifetimes, finds new study – The Lancet

Commentary: Intimate partner violence against women: a persistent and urgent challenge – The Lancet

Commentary on Twitter (thread – click for more)

NEW—Over 1 in 4 women have experienced intimate partner violence in their lifetimes, study finds.

Authors highlight urgent need to strengthen the public health response in post-COVID-19 reconstruction efforts. https://t.co/yZ61fqIZlV pic.twitter.com/AeMSicRUY0

— The Lancet (@TheLancet) February 17, 2022

German Guidelines for the diagnosis, therapy and follow-up of cervical cancer – Part 1 with recommendations on epidemiology, screening, diagnostics and therapy.

17 Feb, 2022 | 08:47h | UTC

Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy – Geburtshilfe und Frauenheilkunde

FIMS / EFSMA Joint position statement on the International Olympic Committee framework on fairness, inclusion and non-discrimination based on gender identity and sex variations.

13 Feb, 2022 | 22:17h | UTC

Joint position statement of the International Federation of Sports Medicine (FIMS) and European Federation of Sports Medicine Associations (EFSMA) on the IOC framework on fairness, inclusion and non-discrimination based on gender identity and sex variations – BMJ Open Sport & Exercise Medicine

Original Guidance: IOC Framework on fairness, inclusion and non-discrimination on the basis of gender identity and sex variations – International Olympic Committee

Commentary: International Olympic Committee transgender guidance criticised by medical experts – BBC

Commentary on Twitter

You do not have to agree with all content in this position statement. But surely we can agree that we need further debate and discussion (and consultation with all stakeholders) to protect the rights of all athletes. #OpenAccess ➡️ https://t.co/xIfnsyk7FV #Diversity #Inclusion pic.twitter.com/2c9S8lGCoa

— BMJ Open Sport & Exercise Medicine (@BMJOpenSEM) January 20, 2022